Synthesis of New, Potentially Biologically Active Derivatives of 1,3,4-Oxadiazole-2-yl carbothioates

2017

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.26577/2218-7979-2017-10-1-57-61
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

It is well known that the derivatives of nitrogenous heterocycles have a wide range of biological activity (antituberculosis, antimicrobial, antitumor, antimalarial, anti-inflammatory, etc.), and oxadiazole derivatives also play same important role. In the current work, in order to synthesize the initial synthons we were carried out the esterification of benzoic (1) and isonicotinic (2) acids were obtained the corresponding ethers (3, 4). Further, interaction with hydrazine hydrate, the corresponding acid hydrazides were synthesized (5, 6). As a result of the cyclization reaction with carbon disulfide were obtained substituted 1,3,4-oxadiazole-2-thiols (7, 8). Finally compounds 7, 8 undergo the alkylation reaction lead to yield two new compounds S-5-phenyl-1,3,4-oxadiazol-2-yl O-propyl carbonothioate (9) and S-5- (pyridin-4-yl) -1,3,4-oxadiazol-2-yl carbonothioate (10). The structures of synthesized compounds were confirmed by NMR spectra. The physico-chemical characteristic data of synthesized compounds were in full agreement with corresponded compounds in reference. The synthesized new compounds have an interest for further investigation of biological activities.